Skip to content
Screener

Kestra Medical Technologies KMTS Q1 2026 earnings

Reported September 11, 2025 · After market close

Revenue$19.4MMiss by $1.4M
EPS-$0.46Beat by $0.20
Revenue estimate$20.7M
EPS estimate-$0.66

Next report

Dec 10, 2026 (in 2 months)
Revenue estimate$32.0M
EPS estimate-$0.61

Financials

Q1 2026

Income statement

See full
Revenue$19.4M+51.5%
Gross profit$8.9M+111%
Operating income-$28.9M-56.7%
Net income-$25.8M-29.9%
EPS (diluted)-$0.50+55.4%

Balance sheet

See full
Cash & equivalents$201.2M+101%
Total debt$44.6M—
Total assets$266.3M—

Cash flow

See full
Operating cash flow-$26.3M-50.1%
CapEx$8.2M+16.0%
Free cash flow-$34.4M-40.4%

Valuation & ratios

Valuation

as of 07/31/25
See full
Market cap$847.25M—
Enterprise value$690.63M—
P/S12.8×—

Profitability

See full
Gross margin43.5%+30.2pp
Operating margin-175.9%-38.5pp
Net margin-180.3%-44.7pp
FCF margin-166.3%-44.3pp

Returns & leverage

See full
Current ratio6.8×—

FAQ

When did Kestra Medical Technologies report Q1 2026 earnings?
Kestra Medical Technologies (KMTS) reported Q1 2026 earnings on September 11, 2025 after market close.
What were Kestra Medical Technologies's Q1 2026 revenue and EPS?
Kestra Medical Technologies reported revenue of $19.4M and eps of $-0.46 for Q1 2026.
Did Kestra Medical Technologies beat estimates in Q1 2026?
Revenue missed the consensus estimate of $20.7M by $1.4M. EPS beat the consensus estimate of $-0.66 by $0.20.
Where can I find Kestra Medical Technologies's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000950170-25-114228) and the 10-Q periodic report (0000950170-25-114536) directly on SEC EDGAR. The filing index links above go to sec.gov.